Liftid is a technology designed to enhance brain performance through transcranial direct current stimulation (tDCS). It improves focus and increases blood flow using a headband with electrodes.
Using Liftid is simple: soak the cotton in liquid and place it on the part of the headband that touches your head. Then, position the device properly on your head. When you turn on the device using the button at the bottom, it beeps and begins sending signals to stimulate your brain.
The product’s guidance book outlines who should not use Liftid. According to Dr. Schwartz, using Liftid for 20 minutes can help maximize attention and focus.
Company Name | Liftid |
Founder | Ken Davidov and Alyson Davidov |
Product | transcranial neuro-stimulation device for improving focus |
Asked For | $200,000 for 10% Equity |
Final Deal | No Offer |
Shark | No Shark |
Episode (Shark Tank USA) | Season 12 Episode 5 |
Air Date | November 13, 2020 |
Business Status | In Business |
Lifetime Sales | $6 Million *estimated |
Who Is The Founder Of Liftid?
Theodore H. Schwartz, MD, is the inventor of Liftid and the developer of Transcranial Direct Current Stimulation (tDCS).
Schwartz graduated from Harvard University, earning both an undergraduate and a medical degree.
He specializes in the surgical treatment of brain tumors, pituitary tumors, and epilepsy, using advanced techniques such as computer-guided surgical navigation, minimally invasive endoscopy, and microsurgery.
Did Liftid Get a Deal on Shark Tank?
Allyson approached the Sharks seeking $200,000 for a 10% equity stake in her company after its appearance on Shark Tank.
She conducted a successful demo to help the Sharks better understand her product.
When Kevin inquired about the product’s sales, Allyson revealed that by October 1st, 2020, the company had sold 1,240 units. The manufacturing cost, including duties, was $22, while the product was sold for $149, resulting in $126,000 in sales during that period.
Lori declined to invest, stating she preferred products that deliver tangible physical changes, rather than those that rely on promises of weight loss or appearance enhancement.
Robert acknowledged the company’s strong sales but felt the product’s quality wasn’t justified enough, leading him to opt out.
Kevin O’Leary also decided not to invest.
Mark Cuban criticized the presentation, saying, “You tried to sell science without using science,” and declined to invest as well.
Liftid’s estimated net worth is $7 million, based on the company’s lifetime sales and valuation data.